EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 26.47
-0.53 (-1.98%)
Mar 5, 2026, 12:11 PM GMT
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 116.59 million as of March 5, 2026. Its market cap has increased by 8.65% in one year.
Market Cap
116.59M
Enterprise Value
102.24M
Revenue
50.22M
Ranking
n/a
PE Ratio
19.99
Stock Price
26.47
Market Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 116.59M, an increase of 5,028.26%. That is a compound annual growth rate of 18.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 109.25M | -4.64% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 236.55B |
| GSK plc | 87.41B |
| Haleon | 35.62B |
| Smith & Nephew | 11.16B |
| Scancell Holdings | 135.95M |
| Diaceutics | 126.10M |
| Shield Therapeutics | 104.17M |
| 4basebio | 89.77M |